{
  "author": {
    "name": "Christopher Yasiejko",
    "webUrl": "/author/profile/christopher-yasiejko/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2018/05/07/kill-drug-patents-to-quell-the-opioid-epidemic/",
        "title": "Kill drug patents to quell the opioid epidemic?",
        "byline": "Christopher Yasiejko  and Anna Edney",
        "kicker": "Commentary",
        "prettyDate": "May 07, 2018",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/DrugRX.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/christopher-yasiejko/",
            "name": "Christopher Yasiejko"
          },
          {
            "webUrl": "/author/profile/anna-edney/",
            "name": "Anna Edney"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "By overriding patents for opioid antidotes, the government could lower the costs and increase availability of the life-saving drugs.",
        "body": null
      }
    ]
  }
}